Published February 2014 | Version v1
Journal article

Clinical analysis of 260 patients with nodular goiter and hyperthyroidism treated by 131I

  • 1. Department of Nuclear Medicine, The Second Affiliated Hospital of Guangxi University of Science and Technology, Liuzhou (China)
  • 2. Graduate School of Guangxi University of Science and Technology, Liuzhou (China)
  • 3. Department of Nuclear Medicine, Affiliated Tumor Hospital of Guangxi Medical University, Nanning (China)

Description

Objective: To study the treatment effect of 131I in nodular goiter and hyperthyroidism. Methods: The thyroid nodules numbers and iodine absorption rate in 260 patients confirmed with nodular goiter and hyperthyroidism were determined, and the patients were treated with 131I and followed-up for 3 to 60 months. The patients were then given levothyroxine sodium 25-150 g/day based on their health situation to inhibit the increase TSH and hypothyroidism. Results: The curative rate of hyperthyroidism with 131I treatment was 65.39%, and partial rate was 20.0%, and hypothyroidism rate was 14.61%. After 131I treatment, 78.85% of nodules was eliminated, nodular narrow accounted for 15.39% and nodular invalid accounted for 5.77%. The curative effect of smaller diameter nodal was better than larger ones (P < 0.05). Conclusion: 131I therapy is suitable method for nodular goiter and hyperthyroidism treatment with good curative effect, especially for patients with surgery contraindication. (authors)

Additional details

Publishing Information

Journal Title
Labeled Immunoassays and Clinical Medicine
Journal Volume
21
Journal Issue
1
Journal Page Range
p. 42-44
ISSN
1006-1703

Optional Information

Notes
1 tab., 7 refs.; http://dx.doi.org/10.11748/bjmy.issn.1006-1703.2014.01.014